Facts, not Fantasy

Friday, December 18, 2009

From Pharyngula: A contest gets a winner: common creationist claims refuted

Today I want to post a blog entry from Pharyngula (A PZ Myers who is a biologist). I understand that he is a controversial figure, and he is very outspoken on some other issues... However, this particular post was about debunking a couple of specific claims used quite often by creationists and those who deny evolution. And as such I felt it was relevant. Not only that, but the particular person PZ is writing about has agreed to allow me to copy a much longer list of debunking that will become a permanent part of this web page. What follows is a copy/paste from the PZ Myers blog:

Once upon a time, in vague exasperation at a persistent creationist, I opened up two of his questions to the Pharynguloid horde in a contest to see who could answer them most clearly and succinctly. I shouldn't have done this; I'm lazy, and this was too much like grading term papers. Still, there were a lot of good answers, so it was a worthwhile effort.

The winner, judged for clarity, brevity, and accuracy, was Calilasseia, an infrequent commenter here who clearly needs to increase his or her frequency. I've sent off an email in hopes of a reply with a mail address, or if Calilasseia notices this, maybe I'll be sent one soon. Or not. The Prize in this contest is an appropriate and ironic one: a copy of Slaughter of the Dissidents, by the incredible Jerry Bergman. Only the first volume, though; he hasn't finished writing the other dozen or so he says are in the offing.

I feel a little guilty. That's like going on a game show, picking door #2, and discovering that your prize is a goat. In this case, it's a GOAT ON FIRE, which helps a little bit, but still…I'll also slip in a surprise book of a more worthy nature if Calilasseia gets back to me.

Here are the two questions and the winning answers. I repeat, these aren't the only good answers—go back to that thread and browse and there are plenty of well written short replies.

Was evolution a significant and essential factor in guiding Nazi thought?

No. First of all, as has already been established courtesy of searching through Mein Kampf in detail, Hitler's assorted eructations on nature reproduce well-known creationist canards, including the static species fallacy, and Hitler also asserted that fertile, viable hybrids were inpossible, which is manifestly refuted by this scientific paper (among many others):

Speciation By Hybridisation In Heliconius Butterflies, by Jesús Mavárez, Camilo A. Salazar, Eldredge Bermingham, Christian Salcedo, Chris D. Jiggins and Mauricio Linares, Nature, 441: 868-871 (15th June 2006)

Also, even an elementary search of Mein Kampf reveals the following statistics. The number of instances of key words are as follows:

"Darwin" : ZERO

"Almighty" : 6

"God" : 37

"Creator" : 8

Hitler was inspired by the anti-Semitic ravings of one Lanz von Liebenfels, who was a defrocked monk, and whose magnum opus bore the Pythonesque title of Theozoology, Or The Account Of The Sodomite Apelings And The Divine Electron. This was in effect a warped Biblical exegesis, which rewrites the Crucifixion story, and also contains a mediaeval bestiary replete with instances of Liebenfels' florid imagination.

Additionally, the Nazis placed textbooks on evolutionary biology on their list of seditious books to be burned, as illustrated nicely here, where we learn that in 1935, Nazi guidelines with respect to seditious books included:

6. Schriften weltanschaulichen und lebenskundlichen Charakters, deren Inhalt die falsche naturwissenschaftliche Aufklärung eines primitiven Darwinismus und Monismus ist (Häckel).

Translated into English, this reads:

Writings of a philosophical and social nature whose content deals with the false scientific enlightenment of primitive Darwinism and Monism (Häckel)

The evidence is therefore conclusive. Nazism was not inspired by evolution, and indeed, much of Hitler's own writings are creationist in tone. The Nazis destroyed evolutionary textbooks as seditious (much as modern day creationists would love to), and the Nazi view of the biosphere is wholly at variance with genuine evolutionary theory, involving fatuous views of race "purification" by the establishment of monocultures that are the very antithesis of genuine evolutionary thought, which relies upon genetic diversity.

Can natural processes produce an increase in complexity?

The overwhelming evidence from the scientific literature is yes. Appropriate papers include:

Evolution Of Biological Complexity by Christoph Adami, Charles Ofria and Travis C. Collier, Proceedings of the National Academy of Sciences of the USA, 97(9): 4463-4468 (25th April 2000)

Evolution of Biological Information by Thomas D. Schneider, Nucleic Acids Research, 28: 2794-2799 (2000)

Indeed, in the latter paper, Schneider establishes that selection processes cause the amount of information in the genome to increase to a maximum.

Likewise, instances of this taking place in real world organisms are well documented in the scientific literature. Such as Lenski's landmark paper on historical contingency in Escherichia coli, the literature centred upon nylonase, and the evolution of antifreeze glycoproteins in Antarctic Notothenioid fishes. From the world of aquarium fishes, there is also a well documented mutation known as the double tail mutation, which results in indivduals of Betta splendens inheriting the mutation developing two complete tail fins, a mutation that moreover, obeys single-factor Mendelian inheritance. This constitutes an example of increase in organismal complexity, that comes about as close to realising creationist canards with respect thereto, as any observed instance in Nature is ever likely to.

More to the point, there exist numerous papers covering de novo origination of genes, of which:

De Novo Origination Of A New Protein-Coding Gene In Saccharomyces cerevisiae by Jing Cai, Ruoping Zhao, Hifeng Jiang and Wen Wang, Genetics, 179: 487-496 (May 2008)

is merely one of the more spectacular instances. Surely the emergence of a gene where previously there was none, constitutes an increase in complexity by any reasonable measure? Particularly as the instance in the above paper arose from a previously noncoding DNA sequence?

Thursday, December 10, 2009

Why Does the Vaccine/Autism Controversy Live On?

I just got my newest issue of Discover Magazine, and it's the end of the year issue with the traditional end of year lists. The #1 item on their list for this year is the whole autism/vaccine non-sense. Sadly, that particular article isn't online yet, so instead I will start off this one from back in May/June.

Research has soundly disproved the alleged connection, yet fears about vaccines continue to be a major risk to public health.by Chris Mooney
From the June 2009 issue, published online May 6, 2009

Vaccines do not cause autism. That was the ruling in each of three critical test cases handed down on February 12 by the U.S. Court of Federal Claims in Washington, D.C. After a decade of speculation, argument, and analysis—often filled with vitriol on both sides—the court specifically denied any link between the combination of the MMR vaccine and vaccines with thimerosal (a mercury-based preservative) and the spectrum of disorders associated with autism. But these rulings, though seemingly definitive, have done little to quell the angry debate, which has severe implications for American public health.

The idea that there is something wrong with our vaccines—that they have poisoned a generation of kids, driving an “epidemic” of autism—continues to be everywhere: on cable news, in celebrity magazines, on blogs, and in health news stories. It has had a particularly strong life on the Internet, including the heavily trafficked Huffington Post, and in pop culture, where it is supported by actors including Charlie Sheen and Jim Carrey, former Playboy playmate Jenny McCarthy, and numerous others. Despite repeated rejection by the scientific community, it has spawned a movement, led to thousands of legal claims, and even triggered occasional harassment and threats against scientists whose research appears to discredit it.

You can see where the emotion and sentiment come from. Autism can be a terrible condition, devastating to families. It can leave parents not only aggrieved but desperate to find any cure, any salvation. Medical services and behavioral therapy for severely autistic children can cost more than $100,000 a year, and these children often exhibit extremely difficult behavior. Moreover, the incidence of autism is apparently rising rapidly. Today one in every 150 children has been diagnosed on the autism spectrum; 20 years ago that statistic was one in 10,000. “Put yourself in the shoes of these parents,” says journalist David Kirby, whose best-selling 2005 book, Evidence of Harm, dramatized the vaccine-autism movement. “They have perfectly normal kids who are walking and happy and everything—and then they regress.” The irony is that vaccine skepticism—not the vaccines themselves—is now looking like the true public-health threat.

The decadelong vaccine-autism saga began in 1998, when British gastroenterologist Andrew Wakefield and his colleagues published evidence in The Lancet suggesting they had tracked down a shocking cause of autism. Examining the digestive tracts of 12 children with behavioral disorders, nine of them autistic, the researchers found intestinal inflammation, which they pinned on the MMR (measles, mumps, and rubella) vaccine. Wakefield had a specific theory of how the MMR shot could trigger autism: The upset intestines, he conjectured, let toxins loose in the bloodstream, which then traveled to the brain. The vaccine was, in this view, effectively a poison. In a dramatic press conference, Wakefield announced the findings and sparked an instant media frenzy. For the British public, a retreat from the use of the MMR vaccine—and a rise in the incidence of measles—began.

In the United States, meanwhile, fears would soon arise concerning another means by which vaccines might induce autism. Many vaccines at the time contained thimerosal, a preservative introduced in the 1930s to make vaccines safer by preventing bacterial contamination. But thimerosal is 50 percent mercury by weight, and mercury is known to be a potent neurotoxin, at least in large doses. In 1999 new federal safety guidelines for mercury in fish stirred concerns about vaccines as well.

The U.S. government responded by ordering that thimerosal be removed from all vaccines administered to children under age 6, or reduced to trace amounts. (Some inactivated influenza vaccines were exempted.) The step was described as a “precautionary” measure. There was no proof of harm, government researchers said, just reason to worry that there might be. Meanwhile, scientists launched numerous studies to determine whether thimerosal had actually caused an autism epidemic, while some parents and their lawyers started pointing fingers and developing legal cases.

Within weeks of this year’s federal court decisions—which examined and vindicated both the MMR vaccine and thimerosal—environmental lawyer Robert F. Kennedy Jr. wrote a column in The Huffington Post in which he continued to press his case that the government has peddled unsafe vaccines to an unsuspecting public. It is a cause he has championed since 2005, when he published “Deadly Immunity” in Rolling Stone and Salon magazines. The article was a no-holds-barred denunciation of the U.S. public-health establishment, purporting to tell the story of how “government health agencies colluded with Big Pharma to hide the risks of thimerosal from the public…a chilling case study of institutional arrogance, power, and greed.” Half a decade after the original thimerosal concerns were first raised, Kennedy claimed to have found the smoking gun: the transcript of a “secret” 2000 meeting of government, pharmaceutical, and independent researchers with expertise in vaccines. Kennedy’s conclusion: The generational catastrophe was real; our kids had been poisoned. If true, it would be perhaps the greatest biomedical catastrophe in modern history.

But for Kennedy to be right, a growing consensus in the medical establishment had to be wrong. Indeed, Kennedy blasted a leading organ of science that had just vindicated both the MMR vaccine and thimerosal, the Institute of Medicine (IOM). “The CDC [Centers for Disease Control and Prevention] paid the Institute of Medicine to conduct a new study to whitewash the risks of thimerosal,” Kennedy wrote, “ordering researchers to ‘rule out’ the chemical’s link to autism.” In reality, the IOM—a branch of the National Academy of Sciences (NAS), the government’s top independent scientific adviser—carefully creates firewalls between the funding it receives to conduct scientific assessments and the results it ultimately produces. “Funders don’t control the composition of the committee, and they don’t meet with the committee,” says Harvard public-health researcher Marie McCormick, who chaired the IOM vaccine-safety committee in question. “And on no NAS or IOM committee are the members paid; they all work pro bono. There’s no reason for them not to look at the data.”

The same year Kennedy’s article came out, journalist David Kirby published Evidence of Harm—Mercury in Vaccines and the Autism Epidemic: A Medical Controversy. He followed a group of parents from the Coalition for SafeMinds, an autism activist organization. They had grown convinced that vaccines and other environmental factors had caused their children’s conditions. Kirby’s chronicle of the parents’ efforts to publicize the dangers of vaccines became a best seller and greatly advanced SafeMinds’ cause.

Yet even as vaccine hysteria reached a fever pitch in the wake of Kennedy’s and Kirby’s writings, the scientific evidence was leaning strongly in the other direction. In discounting the dangers of both the MMR vaccine and thimerosal, the IOM had multiple large epidemiological studies to rely on. For MMR, the IOM examined 16 studies. All but two, which were dismissed because of “serious methodological flaws,” showed no evidence of a link. For thimerosal, the IOM looked at five studies, examining populations in Sweden, Denmark, the United Kingdom, and the United States (studies that vaccine critics contend were flawed). Since then, further research has strengthened and vindicated the committee’s original conclusion. It is a conclusion that has been “independently reached by scientific and professional committees around the world,” as a recent science journal commentary noted. Either the scientific community has found a clear, reassuring answer to the questions raised about thimerosal in vaccines, or there is a global scientific conspiracy to bury the truth.

Whether the public is hearing the scientific community’s answer is another matter. “It’s not hard to scare people,” says pediatrician and leading vaccine advocate Paul Offit, who himself coinvented a vaccine. “But it’s extremely difficult to unscare them.”

A backlash against vaccine skeptics is beginning to mount. Standing up to fellow celebrities, actress Amanda Peet, who recently vaccinated her baby daughter, has become a spokeswoman for the pro-vaccine group Every Child by Two. Offit’s book Autism’s False Prophets has further galvanized vaccine defenders—not only by debunking the science of those who claim vaccines are dangerous but also by contending that the parents of autistic children and the children themselves are indeed victims, not of vaccines but of medical misinformation.

The provaccine case starts with some undeniable facts: Vaccines are, as the IOM puts it, “one of the greatest achievements of public health.” The CDC estimates that thanks to vaccines, we have reduced morbidity by 99 percent or more for smallpox, diphtheria, measles, polio, and rubella. Averaged over the course of the 20th century, these five diseases killed nearly 650,000 people annually. They now kill fewer than 100. That is not to say vaccines are perfectly safe; in rare cases they can cause serious, well-known adverse side effects. But what researchers consider unequivocally unsafe is to avoid them. As scientists at the Johns Hopkins Bloomberg School of Public Health recently found while investigating whooping cough outbreaks in and around Michigan, “geographic pockets of vaccine exemptors pose a risk to the whole community.”

When it comes to autism, vaccine defenders make two central claims. First, the condition is likely to be mostly genetic rather than environmentally caused; and second, there are reasons to doubt whether there is really a rising autism epidemic at all.

It is misleading to think of autism as a single disorder. Rather, it is a spectrum of disorders showing great variability in symptoms and expression but fundamentally characterized by failed social development, inability to communicate, and obsessive repetitive behavior. Autism generally appears in children at early ages, sometimes suddenly, and its genetic component has long been recognized. Studies have shown that if one identical twin has autism, there is at least a 60 percent chance that the other also does. “From my point of view, it’s a condition associated with genetic defects and developmental biology problems,” says Peter Hotez, a George Washington University microbiologist and father of an autistic child. Hotez, who is also president of the Sabin Vaccine Institute, says, “I don’t think it’s possible to explain on the basis of any vaccine toxin that is acquired after the baby is born.” Still, scientists cannot fully rule out environmental triggers—including various types of toxicity—that might interact with a given individual’s preexisting genetic inclination. Autism is a complex disorder with multiple forms of expression and potentially multiple types of causation that are incompletely understood.

As for whether autism is rising, a number of experts say it is hard to know. Is the increase real, or is it largely the result of more attention to the condition, an expansion of the autism spectrum to embrace many different heterogeneous disorders, a new focus on children classified as autistic in federal special education programs during the 1990s, and other factors? It could be some combination of all these things.

But if environmental triggers of autism cannot be ruled out, the idea that those triggers can be found in the MMR vaccine or in thimerosal has crumbled under the weight of scientific refutation. Epidemiological studies have cast grave doubt on Andrew Wakefield’s MMR hypothesis—and so have subsequent scandals. Nearly all of Wakefield’s coauthors have since retracted the autism implications of their work; The Lancet has also backed away from the study. A series of investigative stories published in The Times of London unearthed Wakefield’s undisclosed ties to vaccine litigation in the U.K. and, more recently, suggested he fabricated his data (which Wakefield denies).

As for thimerosal, government precautions notwithstanding, it was never clear how threatening it might be. The federal mercury standards that first heightened concern were developed for methylmercury, not ethylmercury, the form contained in thimerosal. Ethyl­mercury has less risk of accumulating to a toxic dose because it does not last as long in the body. And, according to the IOM’s 2004 report, there had never been any evidence of a major incident of mercury poisoning leading to autism.

The strongest argument against the idea that thimerosal poisoned a generation of children does not emerge from the body of published studies alone. There is the added detail that although thimerosal is no longer present in any recommended childhood vaccines save the inactivated influenza vaccine—and hasn’t been, beyond trace amounts, since 2001—no one is hailing the end of autism. “If you thought thimerosal was related to autism, then the incidence of autism should have gone down,” Harvard’s McCormick explains. “And it hasn’t.”

In 2005 David Kirby stated that if autism rates didn’t begin to decline by 2007, “that would deal a severe blow to the autism-thimerosal hypothesis.” But as McCormick notes, despite the absence of thimerosal in vaccines, reports of autism cases have not fallen. In a 2008 study published in Archives of General Psychiatry, two researchers studying a California Department of Developmental Services database found that the prevalence of autism had actually continued increasing among the young. Kirby concedes that these findings about the California database represent a “pretty serious blow to the thimerosal-causes-autism hypothesis,” though he does not think they thoroughly bury it. In an interview, he outlined many problems with relying on the California database, suggesting potential confounding factors such as the state’s high level of immigration. “Look, I understand the desire to try to end this and not scare parents away from vaccination,” Kirby says. “But I also feel that sometimes that desire to prove or disprove blinds people on both sides.”

Kirby says—and even some vaccine defenders agree—that some small subgroup of children might have a particular vulnerability to vaccines and yet be missed by epidemiological studies. But the two sides disagree as to the possible size of that group. “If one or two or three children every year are getting autism from vaccines, you would never pick that up,” Offit says. Kirby, in contrast, feels that while the idea of thimerosal as the “one and only cause of autism has gone out the window,” he still believes there is an “epidemic” with many environmental triggers and with thimerosal as a possible contributing factor.

Meanwhile, in the face of powerful evidence against two of its strongest initial hypotheses—concerning MMR and thimerosal—the vaccine skeptic movement is morphing before our eyes. Advocates have begun moving the goalposts, now claiming, for instance, that the childhood vaccination schedule hits kids with too many vaccines at once, overwhelming their immune systems. Jenny McCarthy wants to “green our vaccines,” pointing to many other alleged toxins that they contain. “I think it’s definitely a response to the science, which has consistently shown no correlation,” says David Gorski, a cancer surgeon funded by the National Institutes of Health who in his spare time blogs at Respectful Insolence, a top medical blog known for its provaccine stance. A hardening of antivaccine attitudes, mixed with the despair experienced by families living under the strain of autism, has heightened the debate—sometimes leading to blowback against scientific researchers.

Paul Shattuck did not set out to enrage vaccine skeptics and the parents of autistic children. Currently an assistant professor at the George Warren Brown School of Social Work at Washington University in St. Louis, he has dedicated the last decade of his professional life to helping people with autism in their families. “Some of my dearest friends have kids with autism,” he says.

But in 2006 Shattuck came under fire after he published an article in the journal Pediatrics questioning the existence of an autism epidemic. No one doubts that since the early 1990s the number of children diagnosed with autism has dramatically increased, a trend reflected in U.S. special education programs, where children enrolled as autistic grew from 22,445 in 1994–1995 to 140,254 in 2003–2004. Yet Shattuck’s study found reasons to doubt that these numbers were proof of an epidemic. Instead, he suggested that “diagnostic substitution”—in which children who previously would have been classified as mentally retarded or learning disabled were now being classified on the autism spectrum—played a significant role in the apparent increase.

Shattuck did not reject the idea that rising autism levels might be in part due to environmental causes; he merely showed the increase was largely an artifact of changing diagnostic practices, which themselves had been enabled by rising levels of attention to autism and its listing as a diagnostic category in special education. Yet simply by questioning autism epidemic claims in a prominent journal, he became a target. “People were obviously Googling me and tracking me down,” he recalls. Shattuck emphasizes that most e-mails and calls merely delivered “heartfelt pleas from people with very sick kids who’ve been led to believe a particular theory of etiology.” The bulk weren’t menacing, but a few certainly were.

Others attacked Shattuck’s research on the Web and insinuated that he had fabricated his data or committed scientific misconduct. “It was dismaying to feel like people were calling me a traitor to autistic kids and families,” he says.

“If there has been a more harmful urban legend circulating in our society than the vaccine-autism link,” University of Pennsylvania bioethicist Arthur Caplan wrote in The Philadelphia Inquirer, “it’s hard to know what it might be.” One type of harm, as Shattuck’s story shows, is to individual scientists and the scientific process. There is a real risk that necessary research is being held back as scientists fear working in such a contested field. Shattuck’s experience is not unique. Offit cannot go on a book tour to promote Autism’s False Prophets because of the risk involved in making public appearances. He has received too many threats.

Yet another cost comes in the rush toward unproven, and potentially dangerous, alternative therapies to treat autism. It is easy to sympathize with parents of autistic children who desperately want to find a cure, but this has led to various pseudoremedies whose efficacy and safety have been challenged by science. These include facilitated communication, secretin infusion, chelation therapy (which involves pumping chemicals into the blood to bind with heavy metals such as mercury), and hormonal suppression. It is estimated that more than half of all children with autism are now using “complementary and alternative” treatments.

Disease, however, is the greatest danger associated with holding back vaccines amid the ongoing investigation of dubious claims. Both the vaccinated and the unvaccinated populations are placed at greater risk. Given enough vaccine exemptions and localized outbreaks, it is possible that largely vanquished diseases could become endemic again. (That is precisely what happened with measles in 2008 in the U.K., following the retreat from the MMR vaccine in the wake of the 1998 scare.) The public-health costs of such a development would be enormous—and they would not impact everyone equally. “If vaccine rates start to drop, who’s going to get affected?” Peter Hotez asks. “It’s going to be people who live in poor, crowded conditions. So it’s going to affect the poorest people in our country.”

Paradoxically, the great success of vaccines is a crucial reason why antivaccination sentiment has thrived, some scientists say. Most of the diseases that vaccines protect against have largely been licked. As a consequence, few people personally remember the devastation they can cause. So with less apparently on the line, it is easier to indulge in the seeming luxury of vaccine skepticism and avoidance. Even before the recent spike in attention to thimerosal, members of the public were alarmingly skeptical of vaccines. In a 1999 survey, 25 percent felt their children’s immune systems could be harmed by too many vaccinations, and 23 percent shared the sentiment that children receive more vaccinations than are healthy. There is every reason to think that those numbers—gathered before the vaccine-autism controversy reached anything like its current intensity—have risen since.

In the United States, population pockets with low vaccination rates (such as in Boulder, Colorado, and Ashland, Oregon) have existed for some time, and the great fear among many governmental medical authorities is that high-profile claims about vaccine dangers will widen the phenomenon, with potentially disastrous consequences. Already, medical and religious vaccination exemptions are climbing: In New York State they totaled 4,037 in 2006, nearly twice as many as in 1999. In New Jersey they came to 1,923 in 2006 versus only 727 in 1990. It is not just exemptors: The far larger concern, according to McCormick and others, is those parents referred to as “vaccine hesitaters.” They have heard all the noise about vaccines and will probably get their children shots because they feel they have to, but their skepticism is growing.

Offit points to still another threat: litigation. The wave of autism-related claims filed with the U.S. government’s Vaccine Injury Compensation Program is unprecedented. Since 2001 autism claims have outnumbered nonautism cases almost four to one. Following the science, the court has now dismissed many of them, but there is the possibility that civil litigation will follow. “I still think it’s going to be another 10 years before this really washes out in litigation,” Offit says. If the legal atmosphere becomes too difficult for vaccine manufacturers, they could stop producing them or be forced out of business.

Ultimately, that is why the vaccine-autism saga is so troubling—and why it is so important to explore how science and so many citizens fell out of touch.

“It wouldn’t have been possible without the Internet,” says journalist Arthur Allen, who has covered the vaccine-autism story since 2002, when he wrote a high-profile New York Times Magazine article that took the thimerosal risk seriously. Over time Allen changed his mind, coming to reject the idea that vaccines are to blame. Still, he recognizes why it persists. “If people believe something happened to them, there are so many people on the Web you can find who believe the same thing.” The Internet has become a haven for a number of autism support groups that continually reinforce the vaccine-autism argument. This has led to the radicalization of some elements who have denounced scientists as “vaccine barbarians,” “pharmaceutical and medical killers,” and so on. And after all we have heard about environmental and chemical risks—some accurate, some not—people are now easily persuaded about all manner of toxin dangers.

But if the Internet has made it easier for pockets of antiscience feeling to grow and flourish, scientific authorities also deserve some of the blame. “I don’t think they woke up that this was a serious problem until maybe 2008,” David Gorski says about the growing antivaccine sentiment. George Washington University’s Hotez notes that “the office of the surgeon general, the secretary of Health and Human Services, and the head of the CDC have not been very vocal on this issue.” True, the CDC, the Food and Drug Administration, and other governmental organizations feature accurate and up-to-date information about vaccine risks on their Web sites. But that is very different from launching a concerted communications campaign to ensure that the public retains faith in vaccination.

Some outspoken scientists may have actually increased the polarization on this issue. For example, calling those against vaccines “scientifically illiterate”—or, as CDC vaccine expert Stephen Cochi reportedly put it to one journalist, “junk scientists and charlatans”—may just lead to a further circling of the wagons.

The most promising approach to the vaccine-autism issue comes from the government itself. Consider the work of Roger Bernier, a CDC scientist who turned to emphasizing the public-engagement aspects of the vaccine problem after hearing one parent declare any new government research on the topic “dead on arrival.” The central problem Bernier has confronted: how to deal with a situation in which so many parents are unswervingly convinced that their children have been harmed, in which they could be harming their children even more by using untested therapies, and in which dangerous misinformation abounds.

“There’s no end to the kind of noise people can make about vaccines,” he observes. “And so if you’re in the vaccine community, what’s the best approach to this? I don’t think it is ignoring people.” Instead, Bernier has headed up a series of award-winning projects that bring together average citizens with scientists and policymakers to reach joint recommendations on vaccines, holding public dialogues across the country to break down boundaries between the experts and everybody else, literally putting multiple perspectives around a table. His example suggests that while science’s first and greatest triumph in this area was to develop vaccinations to control or eradicate many diseases, the challenge now—not yet achieved, and in some ways even more difficult—is to preserve public support for vaccine programs long after these scourges have largely vanished from our everyday lives.

“The problem is not only research,” Bernier says. “The problem is trust.”

Chris Mooney will continue to report on the vaccine-autism controversy on his blog, The Intersection.

Tuesday, December 01, 2009

Today in the News (1 Dec 09)

Evolution:
Bacteria 'Invest' Wisely to Survive Uncertain Times, Scientists Report. Like savvy Wall Street money managers, bacteria hedge their bets to increase their chances of survival in uncertain times, strategically investing their biological resources to weather unpredictable environments. In a new study available online and featured on the cover of Cell, UT Southwestern Medical Center researchers describe how bacteria play the market so well. Inside each bacterial cell are so-called genetic circuits that provide specific survival skills. Within the bacteria population, these genetic circuits generate so much diversity that the population as a whole is more tolerant of -- and is more likely to survive -- a wide range of variability in the environment.

New Fossil Plant Discovery Links Patagonia to New Guinea in a Warmer Past. Fossil plants are windows to the past, providing us with clues as to what our planet looked like millions of years ago. Not only do fossils tell us which species were present before human-recorded history, but they can provide information about the climate and how and when lineages may have dispersed around the world. Identifying fossil plants can be tricky, however, when plant organs fail to be preserved or when only a few sparse parts can be found. In the November issue of the American Journal of Botany, Peter Wilf (of Pennsylvania State University) and his U.S. and Argentine colleagues published their recent discovery of abundant fossilized specimens of a conifer previously known as "Libocedrus" prechilensis found in Argentinean Patagonia. This plant was first described in 1938 based on one fossil vegetative branch whose characteristics were said to most closely match those of a living South American dry, cold-climate conifer found in the study area: Austrocedrus (Libocedrus) chilensis, the Cordilleran Cypress.

Mass Extinction: Why Did Half of N. America's Large Mammals Disappear 40,000 to 10,000 Years Ago? Years of scientific debate over the extinction of ancient species in North America have yielded many theories. However, new findings from J. Tyler Faith, GW Ph.D. candidate in the hominid paleobiology doctoral program, and Todd Surovell, associate professor of anthropology at the University of Wyoming, reveal that a mass extinction occurred in a geological instant. During the late Pleistocene, 40,000 to 10,000 years ago, North America lost over 50 percent of its large mammal species. These species include mammoths, mastodons, giant ground sloths, among many others. In total, 35 different genera (groups of species) disappeared, all of different habitat preferences and feeding habits.

Vaccines:
Lyme Disease Vaccine? Tick Saliva Found to Protect Mice from Lyme Disease. A protein found in the saliva of ticks helps protect mice from developing Lyme disease, Yale researchers have discovered. The findings, published in the November 19 issue of Cell Host & Microbe, may spur development of a new vaccine against infection from Lyme disease, which is spread through tick bites. Traditionally, vaccines have directly targeted specific pathogens. This is the first time that antibodies against a protein in the saliva of a pathogen's transmitting agent (in this case, the tick) has been shown to confer immunity when administered protectively as a vaccine.

Availability of Vaccine No Guarantee Public Will Want It. Just because a vaccine is available doesn't mean people will choose to be inoculated, according to new UofT research published amid widespread public confusion around the merit of H1N1 flu shots. The research -- which looked at acceptability of potential future HIV vaccinations among high-risk adults in Los Angeles -- shows many factors come into play when a person is deciding whether or not be vaccinated.

Autism:
Early Intervention for Toddlers With Autism Highly Effective, Study Finds. A novel early intervention program for very young children with autism -- some as young as 18 months -- is effective for improving IQ, language ability and social interaction, a comprehensive new study has found. "This is the first controlled study of an intensive early intervention that is appropriate for children with autism who are less than 2 1/2 years of age. Given that the American Academy of Pediatrics recommends that all 18- and 24-month-old children be screened for autism, it is crucial that we can offer parents effective therapies for children in this age range," said Geraldine Dawson, chief science officer of Autism Speaks and the study's lead author. "By starting as soon as the toddler is diagnosed, we hope to maximize the positive impact of the intervention."

Parent Training Key to Improved Treatment of Behavior Problems in Children With Autism. The serious behavior problems that can occur in children with autism and related conditions can be reduced with a treatment plan that includes medication combined with a structured training program for parents, according to Yale University researchers and their colleagues. Published in the December 2009 issue of the Journal of the American Academy of Child and Adolescent Psychiatry, the study was conducted by the National Institute of Mental Health (NIMH) Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. The 24-week, three-site trial was conducted at Yale, Ohio State University and Indiana University. Lawrence Scahill, professor at Yale School of Nursing and the Yale Child Study Center, is principal investigator at the Yale site.

Tuesday, November 24, 2009

Happy 150th Anniversary Origins of Species

Today is an Evolution only news day in honor of the publishing of the groundbreaking work, "On the origin of Species" by Charles Darwin. Seen by many as a watershed moment in history that put science and the church in direct conflict. I would like to direct you to the Evolution Page. In particular this item:

* Evolution denies god(s).
Nothing in the Theory of Evolution denies the existence of god (or any other deity). At best, it merely contradicts a literal interpretation of either of the two biblical creation stories (and any of the countless other creation stories from other religions/cultures). All that the theory of evolution does is show how everything came to be the way it is without the need for god(s).

So with that said, on to the news for today.

Origin of Life: Generating RNA Molecules in Water. A key question in the origin of biological molecules like RNA and DNA is how they first came together billions of years ago from simple precursors. Researchers in Italy have reconstructed one of the earliest evolutionary steps yet: generating long chains of RNA from individual subunits using nothing but warm water. Many researchers believe that RNA was one of the first biological molecules present, before DNA and proteins; however, there has been little success in recreating the formation on RNA from simple "prebiotic" molecules that likely were present on primordial earth billions of years ago. BLOG NOTE: Okay, so this is more an abiogenesis article, but most evolution denyers are totally oblivious to the difference...

Using Darwin in Helping to Define the Biological Essentiality of Silicon and Aluminium. In this year, 200th anniversary of the birth of Charles Darwin and the 150th anniversary of the publication of On the Origin of Species, a UK scientist has used Darwin's seminal work on Natural Selection in helping to define the biological essentiality of the second (silicon) and third (aluminium) most abundant elements of the Earth's crust. The lack of any clear or significant biological essentiality for both of these elements is a mystery as all other abundant elements of the Earth's crust are known to be biologically essential.

Evolution of Highly Toxic Box Jellyfish Unraveled. With thousands of stinging cells that can emit deadly venom from tentacles that can reach ten feet in length, the 50 or so species of box jellyfish have long been of interest to scientists and to the public. Yet little has been known about the evolution of this early branch in the animal tree of life. In a paper published November 18 in the Proceedings of the Royal Society, NOAA researchers Allen Collins, Bastian Bentlage and Cheryl Lewis Ames of the Northeast Fisheries Science Center's National Systematics Laboratory and colleagues from the University of Kansas, Pacific Biosciences Research Center in Hawaii and the University of Queensland in Australia have unraveled the evolutionary relationships among the various species of box jellyfish, thereby providing insight into the evolution of their toxicity.

'Hobbits' Are a New Human Species, According to Statistical Analysis of Fossils. Researchers from Stony Brook University Medical Center in New York have confirmed that Homo floresiensis is a genuine ancient human species and not a descendant of healthy humans dwarfed by disease. Using statistical analysis on skeletal remains of a well-preserved female specimen, researchers determined the "hobbit" to be a distinct species and not a genetically flawed version of modern humans. Details of the study appear in the December issue of Significance, the magazine of the Royal Statistical Society, published by Wiley-Blackwell.

Paleontologists Find Extinction Rates Higher in Open-Ocean Settings During Mass Extinctions. For many years, paleobiological researchers interested in the history of biodiversity have focused on charting the many ups (evolutionary radiations) and downs (mass extinctions) that punctuate the history of life. Because the preserved record of marine (sea-dwelling) animals is unusually extensive in comparison, say, to that of terrestrial animals such as dinosaurs, it's been easier to accurately calibrate the diversity and extinction records of marine organisms. "Paleontologists now recognize that there were five particularly large, worldwide mass extinction events during the history of life, known among the cognoscenti as 'The Big Five,'" says Miller. "Much ink in research journals has been spilled over the past few decades on papers investigating the causes of these events."

Supervolcano Eruption In Sumatra Deforested India 73,000 Years Ago. A new study provides "incontrovertible evidence" that the volcanic super-eruption of Toba on the island of Sumatra about 73,000 years ago deforested much of central India, some 3,000 miles from the epicenter, researchers report. The volcano ejected an estimated 800 cubic kilometers of ash into the atmosphere, leaving a crater (now the world's largest volcanic lake) that is 100 kilometers long and 35 kilometers wide. Ash from the event has been found in India, the Indian Ocean, the Bay of Bengal and the South China Sea.

Before I hit publish, I would also like to leave you all with a few quotes regarding science and the self correcting mechanism involved.

In science it often happens that scientists say, 'You know that's a really good argument; my position is mistaken,' and then they actually change their minds and you never hear that old view from them again. They really do it. It doesn't happen as often as it should, because scientists are human and change is sometimes painful. But it happens every day. I cannot recall the last time something like that happened in politics or religion. [Carl Sagan, 1987 CSICOP keynote address]

You can't convince a believer of anything; for their belief is not based on evidence, it's based on a deep seated need to believe. [Carl Sagan, Contact]

There are many hypotheses in science which are wrong. That's perfectly all right; they're the aperture to finding out what's right. Science is a self-correcting process. To be accepted, new ideas must survive the most rigorous standards of evidence and scrutiny. [Carl Sagan, Cosmos television series]

Think of how many religions attempt to validate themselves with prophecy. Think of how many people rely on these prophecies, however vague, however unfulfilled, to support or prop up their beliefs. Yet has there ever been a religion with the prophetic accuracy and reliability of science? [Carl Sagan, The Demon-Haunted World: Science As a Candle in the Dark]

Monday, November 16, 2009

Today in the News (16 Nov 09)

Evolution:
Caught In The Act: Butterfly Mate Preference Shows How One Species Can Become Two. Breaking up may actually not be hard to do, say scientists who've found a population of tropical butterflies that may be on its way to a split into two distinct species. The cause of this particular break-up? A shift in wing color and mate preference. In a paper published this week in the journal Science, the researchers describe the relationship between diverging color patterns in Heliconius butterflies and the long-term divergence of populations into new and distinct species.

Ancient Penguin DNA Raises Doubts About Accuracy of Genetic Dating Techniques. Penguins that died 44,000 years ago in Antarctica have provided extraordinary frozen DNA samples that challenge the accuracy of traditional genetic aging measurements, and suggest those approaches have been routinely underestimating the age of many specimens by 200 to 600 percent. In other words, a biological specimen determined by traditional DNA testing to be 100,000 years old may actually be 200,000 to 600,000 years old, researchers suggest in a new report in Trends in Genetics, a professional journal. The findings raise doubts about the accuracy of many evolutionary rates based on conventional types of genetic analysis. BLOG NOTE: I am almost reluctant to post this article, only because of how badly it will be misrepresented by creationists and their ilk, and you know it will... The fact that this shows that many evolutionary steps indicate an older age will escape them. Also, this is for Penguins, not all animals. Furthermore, the temperatures and climate may have some bearing on the results. That science is always learning doesn't seem to be a strenth to them.

Vaccines:
People With Less Education Could Be More Susceptible To The Flu. People who did not earn a high school diploma could be more likely to get H1N1 and the vaccine might be less effective in them compared to those who earned a diploma, new research shows. University of Michigan study looked at a latent virus called CMV in young people, and the body's ability to control the virus. Previous studies have shown that elderly people with less education are less successful at fighting off CMV, but this is the first known study to make that connection in younger adults as well, said study co-author Jennifer Dowd, who began the work while in the Health and Society Scholars program at the U-M School of Public Health. BLOG NOTE: Or is it that people who are less educated are more likely to listen to bimbos like Jenny McCarthy? Stupid is as stupid does?

Whooping Cough Immunity Lasts Longer Than Previously Thought. Immunity to whooping cough lasts at least 30 years on average, much longer than previously thought, according to a new study by researchers based at the University of Michigan and the University of New Mexico. Details are published October 30 in the open-access journal PLoS Pathogens. Once thought to be under control following widespread childhood vaccination, whooping cough (pertussis) has been on the rise since the 1980s in the United States and several other countries. Several explanations have been proposed for the surprising increase in cases, and one leading idea is that the immunity enjoyed by vaccinated or previously exposed people is waning. It has been documented that, in some individuals, immunity has waned over time, but details of how long protection typically lasts and how its waning affects disease transmission have not been clear.

Autism:
Children With Autism Show Slower Pupil Responses, Study Finds. Autism affects an estimated 1 in 150 children today, making it more common than childhood cancer, juvenile diabetes and pediatric AIDS combined. Despite its widespread effect, autism is not well understood and there are no objective medical tests to diagnose it. Recently, University of Missouri researchers have developed a pupil response test that is 92.5 percent accurate in separating children with autism from those with typical development. In the study, MU scientists found that children with autism have slower pupil responses to light change. "No comprehensive study has been conducted previously to evaluate the pupils' responses to light change, or PLR, in children with autism," said Gang Yao, associate professor of biological engineering in the MU College of Agriculture, Food and Natural Resources and the College of Engineering. "In this study, we used a short light stimulus to induce pupil light reflexes in children under both dark and bright conditions. We found that children with autism showed significant differences in several PLR parameters compared to those with typical development."

Language Support In Schools Vital For Children With Autism. Teachers and parents must be vigilant in observing difficulties with language comprehension, reading and spelling in children and young people with autism, Asperger's syndrome and ADHD. "It is important that pupils are offered the support to which they are entitled," says Jakob Åsberg in a new thesis at the University of Gothenburg. "Pupils with these neuropsychiatric disorders are often reported as having problems with spoken and written activities. However, relatively little research has been carried out within the field. Considering how important such skills are for coping independently in school and in working life and society in general, it is of great importance that we become better informed about these issues," considers Jakob Åsberg, who is publicly defending his thesis in psychology.

Why Can't Chimps Speak? Key Differences In How Human And Chimp Versions Of FOXP2 Gene Work. If humans are genetically related to chimps, why did our brains develop the innate ability for language and speech while theirs did not? Scientists suspect that part of the answer to the mystery lies in a gene called FOXP2. When mutated, FOXP2 can disrupt speech and language in humans. Now, a UCLA/Emory study reveals major differences between how the human and chimp versions of FOXP2 work, perhaps explaining why language is unique to humans. Published Nov. 11 in the online edition of the journal Nature, the findings provide insight into the evolution of the human brain and may point to possible drug targets for human disorders characterized by speech disruption, such as autism and schizophrenia. BLOG NOTE: This article has a lot to do with genetics and evolution, but there is a tie in to autism and mental dissorders, so I put it here.

Tuesday, November 10, 2009

Today in the News (10 Nov 09)

Evolution:
Inefficient Selection: New Evolutionary Mechanism Accounts For Some Of Human Biological Complexity. A painstaking analysis of thousands of genes and the proteins they encode shows that human beings are biologically complex, at least in part, because of the way humans evolved to cope with redundancies arising from duplicate genes. "We have found a specific evolutionary mechanism to account for a portion of the intricate biological complexity of our species," said Ariel Fernandez, professor of bioengineering at Rice University. "It is a coping mechanism, a process that enables us to deal with the fitness consequences of inefficient selection. It enables some of our proteins to become more specialized over time, and in turn makes us more complex." Fernandez is the lead author of a paper slated to appear in the December issue of the journal Genome Research. The research is available online now. BLOG NOTE: Of course, people who like to deny science because they have no comprehension of how it actually works will attempt to cite this as another example of science being wrong, as opposed to science getting better.

Speed Limit To The Pace Of Evolution, Biologists Say. Researchers at the University of Pennsylvania have developed a theoretical model that informs the understanding of evolution and determines how quickly an organism will evolve using a catalogue of "evolutionary speed limits." The model provides quantitative predictions for the speed of evolution on various "fitness landscapes," the dynamic and varied conditions under which bacteria, viruses and even humans adapt. A major conclusion of the work is that for some organisms, possibly including humans, continued evolution will not translate into ever-increasing fitness. Moreover, a population may accrue mutations at a constant rate -- a pattern long considered the hallmark of "neutral" or non-Darwinian evolution -- even when the mutations experience Darwinian selection.

Vaccines:
New Strategies To Combat The Flu Virus. New anti-flu drugs could become a reality as a result of a study carried out by academics at the University of Hertfordshire. Dr Andreas Kukol at the University of Hertfordshire's School of Life Sciences led a team which studied the evolution of proteins from more than 2,000 viruses, which included swine, avian and human flu. Antivirals such as Tamiflu act on surface proteins, which are highly variable among different viruses. But the researchers found that, if they went deeper than the surface proteins, they could identify proteins which remain constant in evolution and therefore can be targeted more effectively with antivirals.

Sneezing In Times Of A Flu Pandemic. The swine flu (H1N1) pandemic has received extensive media coverage this year. The World Health Organization, in addition to providing frequent updates about cases of infection and death tolls, recommends hyper vigilance in daily hygiene such as frequent hand washing or sneezing into the crook of our arms. News reports at all levels, from local school closures to airport screenings and global disease surveillance, continue to remind us of the high risk. In times of heightened health concerns, everyday behaviors like sneezing can serve as a reminder to wash our hands or take our vitamins. But, what if we overreact to everyday sneezes and coughs and sniffles? Can these signals transform healthy discretion into an unreasonable fearfulness about germs and more?

Autism:
Handwriting Is Real Problem For Children With Autism. Handwriting skills are crucial for success in school, communication, and building children's self-esteem. The first study to examine handwriting quality in children with autism spectrum disorders (ASD) has uncovered a relationship between fine motor control and poor quality of handwriting in children with ASD, according to research published in the November 10, 2009, issue of Neurology®, the medical journal of the American Academy of Neurology. The study, conducted by researchers at the Kennedy Krieger Institute, compared handwriting samples, motor skills, and visuospatial abilities of children with ASD to typically developing children. The researchers found that overall, the handwriting of children with ASD was worse than typically developing children. Specifically, children with ASD had trouble with forming letters, however in other categories, such as size, alignment, and spacing, their handwriting was comparable to typically developing children. These findings build on previous studies examining motor skills and ASD conducted in 2009 by Kennedy Krieger researchers. BLOG NOTE: As a parent of a child with ASD, I can attest to this first hand! Looking at my own handwriting, you may suspect even more!

Clinical Tests Begin On Medication To Correct Fragile X Defect. NIH-supported scientists at Seaside Therapeutics in Cambridge, Mass., are beginning a clinical trial of a potential medication designed to correct a central neurochemical defect underlying Fragile X syndrome, the most common inherited cause of intellectual disability. There has to date been no medication that could alter the disorder's neurologic abnormalities. The study will evaluate safety, tolerability, and optimal dosage in healthy volunteers. The work is the outcome of basic research that traced how an error in the fragile X mental retardation gene (FMR1) leads to changes in brain connections, called synapses. The changes in turn appear to be the mechanism for learning deficits in Fragile X syndrome. The new trial tests Seaside Therapeutics' novel compound, STX107, that selectively and potently targets the synaptic defect.

Monday, November 02, 2009

Today in the News (2 Nov 09)

Evolution:
Novel Evolutionary Theory For The Explosion Of Life. The Cambrian Explosion is widely regarded as one of the most relevant episodes in the history of life on Earth, when the vast majority of animal phyla first appear in the fossil record. However, the causes of its origin have been the subject of debate for decades, and the question of what was the trigger for the single cell microorganisms to assemble and organize into multicellular organisms has remained unanswered until now. Within a longstanding research collaboration between the Institute for Bioengineering of Catalonia and Bielefeld University together with the Friedrich-Miescher-Institute in Basel and the Marine Biological Laboratory at Woods Hole (Massachusetts), Xavier Fernàndez-Busquets (Barcelona) and Dario Anselmetti (Bielefeld) and their colleagues published online in the journal Molecular Biology and Evolution their biophysical single molecule results on the effect of calcium on the interactions of cell adhesion molecules from marine sponges. These simply organized organisms do not have specialized muscle or nerve cells and nevertheless survived the last 500 million years almost unchanged and are considered a link between the single-cell dominated Precambrian and later multicellular organisms.

A Solution To Darwin's 'Mystery Of The Mysteries' Emerges From The Dark Matter Of The Genome. Biological species are often defined on the basis of reproductive isolation. Ever since Darwin pointed out his difficulty in explaining why crosses between two species often yield sterile or inviable progeny (for instance, mules emerging from a cross between a horse and a donkey), biologists have struggled with this question. New research into this field by basic scientists at Fred Hutchinson Cancer Research Center, published online Oct. 22 in Science Express, suggests that the solution to this problem lies within the "dark matter of the genome": heterochromatin, a tightly packed, gene-poor compartment of DNA found within the genomes of all nucleated cells. "Speciation is one of the most fascinating, unsolved problems in biology," said Harmit Malik, Ph.D., an associate member of the Hutchinson Center's Basic Sciences Division and corresponding author of the paper.

Vaccines:
Pregnant Women At 'Serious Risk' from Flu. Pregnant women who catch the flu are at serious risk for flu-related complications, including death, and that risk far outweighs the risk of possible side effects from injectable vaccines containing killed virus, according to an extensive review of published research and data from previous flu seasons. The review, a collaboration among scientists from the Johns Hopkins Children's Center, Emory University and Cincinnati Children's Hospital, and published online Oct. 22 in the American Journal of Obstetrics & Gynecology, found substantial and persistent evidence of high complication risk among pregnant women -- both healthy ones and those with underlying medical conditions -- infected with the flu virus, while confirming vaccine safety. The findings, researchers say, solidify existing CDC recommendations that make pregnant women the highest-priority group to receive both the H1N1 and seasonal flu vaccines.

Progress Made On Group B Streptococcus Vaccine. Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have completed a Phase II clinical study that indicates a vaccine to prevent Group B Streptococcus (GBS) infection is possible. GBS is the most common cause of sepsis and meningitis in newborns in the United States, according to the Centers for Disease Control and Prevention (CDC). It can also cause severe illness in pregnant women, the elderly and adults with chronic illnesses. Colonization of the genital or gastrointestinal tract is a critical risk factor for infections due to GBS.

Autism:
New 'Schizophrenia Gene' Prompts Researchers To Test Potential Drug Target. Johns Hopkins scientists report having used a commercially available drug to successfully "rescue" animal brain cells that they had intentionally damaged by manipulating a newly discovered gene that links susceptibility genes for schizophrenia and autism. The rescue, described as "surprisingly complete" by the researchers, was accomplished with rapamycin, a drug known to act on a protein called mTOR whose role involves the production of other proteins. The idea to test this drug's effectiveness at rescuing impaired nerve cells occurred to the team as a result of having discovered a new gene that appears to act in concert with two previously identified schizophrenia susceptibility genes, one of which is involved in the activation of the protein mTOR. This piecing together of multiple genes adds support for the idea that susceptibility to schizophrenia and autism may have common genetic fingerprints, according to the researchers.

Vaccine Inoculations Show No Link to Autism, Other Health Problems: Presented at IDSA. Vaccine inoculations show no link to autism or other health problems even in children with certain genetic disorders that might put them at risk for such problems, researchers stated here at the 47th Annual Meeting of the Infectious Diseases Society of America (IDSA). The research findings could contradict previous concessions by the US Department of Health and Human Services that suggested a possibility that vaccination might have aggravated a child's underlying mitochondrial disorder and caused her autism symptoms.

Monday, October 26, 2009

When Mercury isn't really Mercury

Thiomersal fact sheet

Summary


Thiomersal (also known as thimerosal) is a mercury-based preservative used in some vaccines. The level of mercury in vaccines is very low and there is no evidence that thiomersal in vaccines has caused any health problems except minor reactions, such as redness at the injection site. However, because of the potential risk of harm from mercury, thiomersal was removed from most childhood vaccines as a precautionary measure. Follow up studies in children and adults have not shown any harmful effects from thiomersal in vaccines.


The following commonly asked questions are answered in this fact sheet:


What is thiomersal?


Thiomersal, also known as thimerosal, is an organic compound containing 49.6% ethylmercury by weight. It has been used in very small amounts in some vaccines since the 1930s to prevent bacterial and fungal contamination, particularly in multidose vials where withdrawing repeated doses from the same vial was more likely to result in contamination.


In 1999, concerns were raised in the United States that the total amount of mercury, from thiomersal in vaccines given in the infant immunisation schedule, would potentially exceed the recommended level set by a US government agency. There were no studies indicating that the ethylmercury in thiomersal had caused harmful effects in children (except for occasional redness at the injection site); however, it was recommended that thiomersal be removed from many childhood vaccines to eliminate any potential risk. Since that time much more information has been gathered regarding thiomersal ethylmercury).


What is mercury?


Mercury is a metal occurring naturally in the environment. Mercury is found in three main forms: metallic mercury which gives rise to mercury vapour, inorganic mercury (a form in the environment and in animal tissues) and organic mercury (the two main forms of which are methylmercury and ethylmercury). These various forms of mercury are found in the air, earth, aquatic sediment, in fish (particularly in long lived fish such as sharks), and are used in industrial processes, dental fillings, thermometers, and vaccines.


The two organic forms of mercury, methylmercury and ethylmercury (in thiomersal), are closely related but they have important differences. Methylmercury is more potent; it accumulates in the body because the time taken for the body to eliminate it (know as the half life) is about 50 days. Ethylmercury (in thiomersal) does not accumulate in the body to such an extent, because its half life is only about 7-10 days. Ethylmercury is rapidly converted in the body to inorganic mercury, which is excreted in the stool. Mercury can have harmful effects on the central nervous system, skin and kidneys, but most cases of the toxic effects of mercury have been from methylmercury, not ethylmercury.


How much mercury is harmful?


Mercury is harmful only after it reaches a certain level in the body. The toxicity depends on the amount of mercury consumed in relation to body weight, over a period of time. Therefore, because of their size, infants are at greater risk than adults. Different expert bodies have determined that safe levels of mercury consumption lie somewhere between 0.7 µg/kg body weight/week (Environmental Protection Agency, USA) to 3.3 µg/kg of body weight/week (World Health Organization). These values indicate levels of exposure that can be tolerated, and have been deliberately calculated to be much lower than the level at which harm might occur. For example, the EPA level is ten times below the lowest level calculated as causing harm, so there is a large built-in safety margin. In addition, these levels refer to methylmercury, whereas thiomersal is converted to ethylmercury, which is broken down and excreted more rapidly and does not accumulate in the body like methylmercury.


How much mercury exposure results from vaccines?


In Australia, thiomersal has been removed from all routine childhood vaccines since 2000. The exception is one type of Hepatitis B vaccine which contains a greatly reduced amount of thiomersal (see Table 1 below). When thiomersal-containing vaccines were being used before 2000, the maximum number of doses of thiomersal-containing vaccines a 6 month old child might have received was as follows: 3 doses each of diphtheria-tetanus-pertussis vaccine, 3 doses of hepatitis B vaccine, and 3 doses of Hib vaccine. This would have resulted in a total intake of 175 µg of ethylmercury, which is equivalent to about 1.9 µg/kg body weight per week, for an average-sized baby. This level is well below the World Health Organization (WHO) limit for methylmercury discussed above. Two studies measuring mercury levels in the blood in infants given thiomersal-containing vaccines have indicated that their blood concentrations of mercury did not rise above designated levels, except possibly transiently in a premature infant less than 1kg in weight.


In many countries thiomersal continues to be used in vaccines. The Global Advisory Committee on Vaccine Safety (GAVSC) of the WHO has concluded that "there is currently no evidence of mercury toxicity in infants, children or adults exposed to thiomersal-containing vaccines" and that "there is no reason to change current immunisation practices with thiomersal-containing vaccines on the grounds of safety".


What studies have been done to look at the health effects of thiomersal in vaccines?


Many studies in Denmark, Sweden, the United States, and the United Kingdom have now shown that there is no evidence of developmental or neurologic abnormalities resulting from the use of vaccines containing thiomersal. In 2004, a report by the Institutes of Medicine, an independent expert body in the United States, concluded that there is no association between autism and vaccines that contain thiomersal. Also in 2004, an extensive review of all the studies on thiomersal-containing vaccines and autism and neurodevelopmental disorders was published in the journal Pediatrics. Studies looking at autism, mental retardation, speech disorders, and attention deficit disorder, as well as other conditions were reviewed. Overall, the evidence indicated that autism and neurodevelopmental disorders are not associated with thiomersal in vaccines. The reviewers noted that the epidemiologic studies done that suggest a link (notably only by one pair of authors) “have significant design flaws that invalidate their conclusions.”


Why was thiomersal removed from childhood vaccines if there is no danger?


Although there has been a lack of evidence that thiomersal in vaccines is harmful, the recommendations to remove it from vaccines were made for two main reasons. Firstly, it was to reduce exposure in very small premature babies with low body weight in whom there was a theoretical risk that the intake of mercury from repeated doses of thiomersal-containing vaccines could have been high. Secondly, the intent has been to reduce total exposure to mercury in babies and young children in a world where other environmental sources (particularly in food such as fish) may be more difficult to eliminate. Along with these recommendations, guidelines have been developed on limiting the consumption of certain types of fish, particularly in the diet of pregnant women and young children. This advice is available at: http://www.foodstandards.gov.au/whatsinfood/.


In the place of thiomersal, preservatives have either been eliminated from single dose vaccine vials or alternative preservatives have been used. Multidose vaccine vials for are no longer used for routine immunisation in Australia, so the risk of bacterial contamination from withdrawing repeated doses of vaccine is minimal.


What about vaccines for adults?


The levels of mercury in adults resulting from thiomersal-containing vaccines are so low that experts do not recommend removal of thiomersal from vaccines for adolescents or adults. The vaccines available in Australia that currently contain thiomersal are listed below in
Table 2.


Which vaccines contain thiomersal?


All vaccines on the current Australian Standard Vaccination Schedule (ASVS) for infants and children under the age of 8 years are now free of thiomersal. The exception is the one of the infant hepatitis B vaccines, Engerix-B paediatric formulation, which contains a greatly reduced amount of thiomersal (2 µg per dose). The following tables list the vaccines used in Australia that are thiomersal free and vaccines that contain thiomersal.


Table 1:

Thiomersal-free vaccines available for use in infants and children in Australia

VaccineTrade NameManufacturer
Hepatitis BH-B-VaxII*
preservative-free
paediatric formulation
CSL/Merck Sharpe & Dohme
DTPaInfanrix and TripacelGlaxoSmithKline, CSL
DTPa-hepatitis BInfanrix-Hep BGlaxoSmithKline
DTPa-IPVInfanrix-IPVGlaxoSmithKline
DTPa-hepatitis B-IPVInfanrix-PentaGlaxoSmithKline
DTPa-hepatitis B-IPV-Hib B PRPTInfanrix-HexaGlaxoSmithKline
Hepatitis B - Hib B PRP-OMPComvaxCSL
Haemophilus influenzae B OMPLiquid PedVaxHIBMerck Sharpe & Dohme
Haemophilus influenzae B PRPTActHibPasteur Mrieux
Haemophilus influenzae B HbOCHibTITERLederle
Measles, mumps, rubellaMMR II, PriorixCSL, GlaxoSmithKline
Meningococcal group C conjugate vaccinesMeningitec, Menjugate, NeisVac-CWyeth, CSL, Baxter
Oral polio vaccineOPVCSL
Inactivated polio vaccine (IPV)IPOLAventis Pasteur
Polysaccharide pueumococcal vaccinePneumovax 23Merck Sharpe & Dohme
7-valent pneumococcal conjugate vaccinePrevenarLederle
Varicella vaccineVarilrixGlaxoSmithKline
Varicella vaccineVarivaxCSL/Merck Sharpe & Dohme
Influenza vaccineVaxigrip, FluvaxAventis Pasteur, CSL

 

Table 2:

Vaccines available in Australia that contain thiomersal

VaccineTrade NameManufacturerDose of
thiomersal
Combined diphtheria and
tetanus vaccine
CDTCSL50 micrograms
Adult diphtheria and tetanus vaccineADTCSL50 micrograms
Diphtheria vaccine CSL50 micrograms
Hepatitis BEngerix B AdultGlaxoSmithKline<2 micrograms
*Influenza vaccinesFluarix, Influvac, FluvaxGlaxoSmithKline, Solvay, CSL50 micrograms
Japaneseencephalitis vaccineJE VaxCSL35 micrograms
Q fever vaccineQ vaxCSL50 micrograms

*Thiomersal-free influenza vaccines are listed in Table 1.


Further reading


1. Mercury and vaccines (Thimerosal). Centers for Disease Control. Link (accessed November 23, 2004).


2. American Academy of Family Physicians (AAFP), American Academy of Pediatrics (AAP), Advisory Committee on Immunization Practices (ACIP), United States Public Health Service (PHS). Joint Statement concerning removal of thimerosal from vaccines. Link (accessed November 23, 2004).


3. Centers for Disease Control. Mercury and vaccines Fact Sheet. Link (accessed November 23, 2004).


4. Recommendations regarding the use of vaccines that contain thimerosal as a preservative. Morbidity and Mortality Weekly Report 1999. Link (accessed November 23, 2004).


5. Institute of Medicine Immunization Safety Review Committee, Stratton K, Gable A, McCormick MC, editors. 2001. Thimerosal-containing vaccines and neurodevelopmental disorders. Link (accessed November 23, 2004).


6. Institute of Medicine Immunization Safety Review Committee. Vaccines and Autism. Washington, DC: National Academy Press, 2004, in press Prepublication review available at: http://books.nap.edu/catalog/10997.html (accessed November 23, 2004).


7. Institute of Medicine Press Release. MMR Vaccine and Thimerosal-Containing Vaccines Are Not Associated With Autism. May 18, 2004. Link (accessed November 23, 2004).


8. European Agency for the Evaluation of Medicinal Products (EMEA). Statement on thiomersal in vaccines. Link (accessed November 23, 2004).


9. Thiomersal and vaccines:questions and answers. World Health Organisation. Scientific papers. Link (accessed November 23, 2004).


10. Parker SK, Schwartz B, Todd J and Pickering LK. Thimerosal-Containing Vaccines and Autism Spectrum Disorder: A Critical Review of Published Original Data. Pediatrics 2004; 114(3): 793-804


11. Heron J, Golding J, and ALSPAC Study Team. Thimerosal Exposure in Infants and Developmental Disorders: A Prospective Cohort Study in the United Kingdom Does Not Support a Causal Association. Pediatrics 2004; 114(3): 577-583.


12. Study Fails to Show a Connection Between Thimerosal and Autism. Source: American Academy of Pediatrics, May 16, 2003. Link (accessed November 23, 2004).


13. Clements CJ. The evidence for the safety of thiomersal in newborn and infant vaccines.Vaccine. 2004 May 7; 22(15-16): 1854-61.


14. Offit, P.A. and Jew R.K. Addressing Parents' Concerns: Do Vaccines Contain Harmful Preservatives, Adjuvants, Additives, or Residuals? Pediatrics. 2003 112(6): 1854-1861.


15. Madsen KM, Lauritsen MB, Pedersen CB, et al. Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data. Pediatrics 2003; 112: 604-606.


16. Verstraeten T, Davis RL, DeStefano F, Lieu TA, Rhodes PH, Black SB, Shinefield H, and Chen RT. Safety of Thimerosal-Containing Vaccines: A Two-Phased Study of Computerized Health Maintenance Organization Databases. Pediatrics 2003; 112(5): 1039-48.


17. Stehr-Green P, Tull P, Stellfeld M, Mortenson PB, and Simpson D. Autism and thimerosal-containing vaccines: Lack of consistent evidence for an association. American Journal of Preventive Medicine 2003; 25(2): 101-6.


18. Nelson, KB, and Bauman, M.L. Thiomersal and autism? Pediatrics 2003; 111: 674-679.


19. Henderson DC. Mercury in vaccines - reassuring news. Lancet 2002 (Nov 30); 360: 1711-12.


20. Pichichero ME, Cernichiari E, Lopreiato J, Treanor J. Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study. Lancet 2002 (Nov 30); 360: 1737-41.


21. Clements CJ, Ball LK, Ball R, Pratt D. Thiomersal in vaccines. Lancet 2000; 355: 1279-1280.


22. Halsey NA. Limiting infant exposure to thimerosal in vaccines and other sources of mercury [editorial]. Journal of the American Medical Association 1999; 282: 1763-6.


Online resources


* "Sticking Up for Thimerosal: Read the studies — it's safe." To access "Sticking Up for Thimerosal," go to: http://slate.msn.com/id/2123647


* Information about mercury and vaccines can be found at: http://www.cdc.gov/nip/vacsafe/concerns/thimerosal/default.htm#facts


* Information about autism can be found at: http://www.cdc.gov/ncbddd/dd/aic/about/default.htm


* Synopses of articles from the scientific, peer-reviewed literature related to vaccines and immunization can be found at: http://www.immunizationinfo.org/immunization_science.cfm?cat=1


* Thimerosal-related resources for parents/patients can be found at: http://www.vaccineinformation.org/thimerosal.asp


* Journal abstracts related to thimerosal can be found at: http://www.immunize.org/safety/thimerosal.htm#journalarticles


* A transcript from the HHS Media Briefing on Vaccines and Child Health (held July 19, 2005) is at: http://www.cdc.gov/od/oc/media/transcripts/t050719.htm


* FREE DOWNLOAD OF IOM REPORT:

The IOM report "Immunization Safety Review: Vaccines and Autism", released May 2004, is now available to download free as a ready-to-print (PDF) document. To access it, go to: http://www.nap.edu/catalog/10997.html (Click on "sign in to download", and follow the instructions).


This document was prepared by the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases. Updated November, 2004.


This document was written by Associate Professor Raina MacIntyre, Professor Margaret Burgess, Associate Professor Peter McIntyre and Dr Kristine Macartney of the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases.


[Note: This is a repost of last Monday's article, of the same title, because my colleague, Larian LeQuella, made a SNAFU of doing a "copy & paste" job of the HTML tables in the original post; not really his fault, the web-master/developer at the other website, from which the original article was sourced, did not configure the HTML tags for the tables correctly — probably was goofing off at work! — and, consequently, the system here misinterpreted them — which I had to completely debug! Also, this blog works best with CSS rather than HTML tags.]

Thursday, October 22, 2009

Today in the News (22 Oct 09)

Evolution:
Before I start with the news, I did want to point out that "I was right" regarding "Ida" and the media hyper-sensationalism... I think the biggest thing that this points out though is that we have so many scientifically illiterate people around that none of them even could tell that they were jumping to the wrong conclusions, and using incorrect terminology, or a whole host of other dumb mistakes made on the part of the media and the general public.

Tool-making Human Ancestors Inhabited Grassland Environments Two Million Years Ago. In an article published in the open-access, peer-reviewed journal PLoS ONE on October 21, 2009, Dr Thomas Plummer of Queens College at the City University of New York, Dr Richard Potts of the Smithsonian Institution National Museum of Natural History and colleagues report the oldest archeological evidence of early human activities in a grassland environment, dating to 2 million years ago. The article highlights new research and its implications concerning the environments in which human ancestors evolved. Scientists as far back as Charles Darwin have thought that adaptation to grassland environments profoundly influenced the course of human evolution. This idea has remained well-entrenched, even with recent recognition that hominin origins took place in a woodland environment and that the adaptive landscape in Africa fluctuated dramatically in response to short-term climatic shifts.

Are Humans Still Evolving? Absolutely, Says A New Analysis Of A Long-term Survey Of Human Health. Although advances in medical care have improved standards of living over time, humans aren't entirely sheltered from the forces of natural selection, a new study shows. "There is this idea that because medicine has been so good at reducing mortality rates, that means that natural selection is no longer operating in humans," said Stephen Stearns of Yale University. A recent analysis by Stearns and colleagues turns this idea on its head. As part of a working group sponsored by the National Evolutionary Synthesis Center in Durham, NC, the team of researchers decided to find out if natural selection — a major driving force of evolution — is still at work in humans today. The result? Human evolution hasn't ground to a halt. In fact, we're likely to evolve at roughly the same rates as other living things, findings suggest.

Time In A Bottle: Scientists Watch Evolution Unfold. A 21-year Michigan State University experiment that distills the essence of evolution in laboratory flasks not only demonstrates natural selection at work, but could lead to biotechnology and medical research advances, researchers said. Charles Darwin's seminal Origin of Species first laid out the case for evolution exactly 150 years ago. Now, MSU professor Richard Lenski and colleagues document the process in their analysis of 40,000 generations of bacteria, published this week in the international science journal Nature. Lenski, Hannah Professor of Microbial Ecology at MSU, started growing cultures of fast-reproducing, single-celled E. coli bacteria in 1988. If a genetic mutation gives a cell an advantage in competition for food, he reasoned, it should dominate the entire culture. While Darwin's theory of natural selection is supported by other studies, it has never before been studied for so many cycles and in such detail.

Vaccines:
Global Health Experts Report Childhood Vaccines At All-time High, But Access Not Yet Equitable. Reversing a downward trend, immunization rates are now at their highest ever and vaccine development worldwide is booming, according to a new assessment released today by the World Health Organization (WHO), UNICEF and the World Bank. The State of the World's Vaccines and Immunization reports that more infants are being immunized today than ever before -- a record 106 million in 2008 -- according to new data. At the same time, its authors are calling on donor nations to address a funding gap that leaves millions of children still at risk, particularly in the poorest nations and communities, where preventable diseases take their deadliest toll.

H1N1 Simulation Modeling Shows Rapid Vaccine Rollout Effective In Reducing Infection Rates. Early action, especially rapid rollout of vaccines, is extremely effective in reducing the attack rate of the H1N1 influenza virus, according to a simulation model of a pandemic outbreak reported in a new study in CMAJ (Canadian Medical Association Journal). The article presents a simulation model that projects how many people will be infected under different disease control strategies. The model simulated a pandemic outbreak based on demographic information from London, a mid-sized city in Ontario, Canada as well as epidemiologic influenza pandemic data. It looked at the impact of vaccination timing, school closures and antiviral drug treatment strategies as well as the effect of pre-existing immunity.

Autism:
I put this in the category of "We wasted a bunch of money to shut you up, and it still probably won't matter..." Mercury Levels In Children With Autism And Those Developing Typically Are The Same, Study Finds. In a large population-based study published online today, researchers at the UC Davis MIND Institute report that after adjusting for a number of factors, typically developing children and children with autism have similar levels of mercury in their blood streams. Mercury is a heavy metal found in other studies to adversely affect the developing nervous system. The study, appearing in the journal Environmental Health Perspectives, is the most rigorous examination to date of blood-mercury levels in children with autism. The researchers cautioned, however, that the study is not an examination of whether mercury plays a role in causing the disorder.

Possible Link Between Autism And Oxytocin Gene Via Non-DNA Sequence Mutation. Researchers at Duke University Medical Center have uncovered a new genetic signature that correlates strongly with autism and which doesn't involve changes to the DNA sequence itself. Rather, the changes are in the way the genes are turned on and off. The finding may suggest new approaches to diagnosis and treatment of autism. The researchers found higher-than-usual numbers of gene-regulating molecules called methyl groups in a region of the genome that regulates oxytocin receptor expression in people with autism.